ArticleJournal of Cancer2019
Prognostic Factors and Recurrence Patterns in T4 Gastric Cancer Patients after Curative Resection.
Article in Journal of Cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 35 citations in OpenAlex.
- Research progress on the application of dual energy CT in gastric diseases.Frontiers in medicine · 2026Review
- Novel inflammatory-nutritional prognostic index for advanced gastric cancer patients undergoing gastrectomy and prophylactic hyperthermic intraperitoneal chemotherapy.World journal of gastrointestinal surgery · 2025Article
- Comprehensive Analyses of Single-Cell and Bulk RNA Sequencing Data From M2 Macrophages to Elucidate the Immune Prognostic Signature in Patients with Gastric Cancer Peritoneal Metastasis.ImmunoTargets and therapy · 2025Article
- A quantitative model using multi-parameters in dual-energy CT to preoperatively predict serosal invasion in locally advanced gastric cancer.Insights into imaging · 2024Article
- Exosomal miR-493 suppresses MAD2L1 and induces chemoresistance to intraperitoneal paclitaxel therapy in gastric cancer patients with peritoneal metastasis.Scientific reports · 2024Article
- Vagus nerve signal has an inhibitory influence on the development of peritoneal metastasis in murine gastric cancer.Scientific reports · 2024Article
- Short-and long-term outcomes of one-stage versus two-stage gastrectomy for perforated gastric cancer: a multicenter retrospective propensity score-matched study.World journal of surgical oncology · 2024Article
- Risk stratification for predicting postoperative recurrence of gastric cancer by grade of venous invasion.BMC gastroenterology · 2023Article
- Inflammatory Ratios as Predictors for Tumor Invasiveness, Metastasis, Resectability and Early Postoperative Evolution in Gastric Cancer.Current oncology (Toronto, Ont.) · 2022Article
- An Analysis of Tolerance and Early Survival Outcomes with Perioperative Modified FLOT in Gastric Cancers.South Asian journal of cancer · 2022Article
- Short-term safety and Long-term efficacy of multivisceral resection in pT4b gastric cancer patients without distant metastasis: a 20-year experience in China National Cancer Center.Journal of Cancer · 2022Article
- Impact of Pancreatic Resection on Survival in Locally Advanced Resectable Gastric Cancer.Cancers · 2021Article
- Incidence, Risk Factors and Prognosis of T4a Gastric Cancer: A Population-Based Study.Frontiers in medicine · 2021Article
- Survival times are similar among patients with peritoneal, hematogenous, and nodal recurrences after curative resections for gastric cancer.Cancer medicine · 2020Article
- Reduced expression of exosomal miR‑29s in peritoneal fluid is a useful predictor of peritoneal recurrence after curative resection of gastric cancer with serosal involvement.Oncology reports · 2020Article
- Exosomal microRNA in peritoneal fluid as a biomarker of peritoneal metastases from gastric cancer.Annals of gastroenterological surgery · 2020Article
- Clinical Significance of Tumor and Immune Cell PD-L1 Expression in Gastric Adenocarcinoma.In vivo (Athens, Greece)Article
- Tumor Depth Prediction of Gastric Cancer With a T4 Score.Cancer diagnosis & prognosisArticle
- Reducing Malignant Ascites and Long-Term Survival in a Patient with Recurrent Gastric Cancer Treated with a Combination of Docetaxel and Mistletoe Extract.Case reports in oncologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.